Allopurinol description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Allopurinol

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ALLOPURINOL DESCRIPTION


Allopurinol







CLINICAL PHARMACOLOGY










INDICATIONS AND USAGE





INDICATIONS & USAGE


CLINICAL PHARMACOLOGYCONTRAINDICATIONSWARNINGSPRECAUTIONS





ALLOPURINOL CONTRAINDICATIONS



WARNINGS


CLINICAL PHARMACOLOGY




PRECAUTIONS

General







INFORMATION FOR PATIENTS




LABORATORY TESTS


WARNINGS


DRUG INTERACTIONS

CLINICAL PHARMACOLOGY








Drug/Laboratory Test Interactions


PREGNANCY





NURSING MOTHERS



PEDIATRIC USE

INDICATIONS AND USAGEDOSAGE AND ADMINISTRATION

ALLOPURINOL ADVERSE REACTIONS

PRECAUTIONSDOSAGE AND ADMINISTRATION
WARNINGSPRECAUTIONS

Most Common Reactions*
Probably Causally Related



ADVERSE REACTIONSINDICATIONS AND USAGEPRECAUTIONSDOSAGE AND ADMINISTRATION

Incidence Less Than 1%
Probably Causally Related









PRECAUTIONS

Incidence Less Than 1%
Causal Relationship Unknown












OVERDOSAGE





DOSAGE & ADMINISTRATION












HOW SUPPLIED














PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Allopurinol



Allopurinol






Allopurinol

Allopurinol TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-161(NDC:0591-5544-05)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ALLOPURINOL ALLOPURINOL 300 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
STARCH, CORN
SODIUM LAURYL SULFATE
FD&C YELLOW NO. 6

Product Characteristics

Color Size Imprint Code Shape
orange 11 mm DAN;DAN;5544 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-161-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090637 2011-04-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.